Advise females of reproductive potential of potential risk to a fetus and to use effective contraception during therapy. Embryo-Fetal Toxicity: Can cause fetal harm. ![]() Monitor CBC every 2 weeks for the first 2 cycles, at the beginning of each subsequent 4 cycles, and as clinically indicated. Neutropenia: Perform complete blood count (CBC) before initiating therapy with KISQALI.Monitor LFTs every 2 weeks for the first 2 cycles, at the beginning of each subsequent 4 cycles, and as clinically indicated. ![]() Perform liver function tests (LFTs) before initiating treatment with KISQALI.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |